Ai Ken Pharma

Ai Ken Pharma is a Japanese pharmaceutical distribution and wholesale company specializing in the Southeast Asian market, with a primary focus on Cambodia and Laos. Founded by Kentaro Imamoto, the company serves as a "Japanese Bridge for Healthcare Needs in Asia," providing full-agency services for ethical pharmaceuticals, medical devices, and biomaterials. Its portfolio includes high-profile oncology treatments such as TS-ONE and Lonsurf, as well as nutritional supplements and surgical materials. In late 2024, the company established its regional headquarters in Singapore to drive strategic expansion and manage its growing network of partnerships, including a significant alliance with Alfresa Holdings.